Literature DB >> 6352744

An improved chromogenic substrate endotoxin assay for clinical use.

R I Harris, P C Stone, J Stuart.   

Abstract

An improved quantitative assay for endotoxin in plasma was developed after evaluating three different chromogenic substrates and seven methods for removal of plasma inhibitors. Optimal storage conditions for plasma samples prior to assay were also determined. Using chromogenic substrate S2423 with plasma diluted 1/10 in water and heated to 75 degrees C for 5 min to remove inhibitors, a within-batch coefficient of variation of 4% was obtained at levels of endotoxin likely to be encountered clinically. The limit of assay sensitivity was less than 10 pg/ml. This assay provides a sensitive quantitative test for single episodes of endotoxaemia in individual patients but variable activation of the Limulus proenzyme by endotoxin from different bacterial strains limits quantitative comparisons between patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6352744      PMCID: PMC498492          DOI: 10.1136/jcp.36.10.1145

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  The inactivation of endotoxin after interaction with certain proteins of normal serum.

Authors:  R C Skarnes
Journal:  Ann N Y Acad Sci       Date:  1966-06-30       Impact factor: 5.691

2.  Relation of renal impairment and haemorrhagic diathesis to endotoxaemia in fulminant hepatic failure.

Authors:  S P Wilkinson; V Arroyo; B G Gazzard; H Moodie; R Williams
Journal:  Lancet       Date:  1974-03-30       Impact factor: 79.321

3.  A technique for quantitative measurement of endotoxin in human plasma.

Authors:  R B Reinhold; J Fine
Journal:  Proc Soc Exp Biol Med       Date:  1971-05

4.  New limulus amoebocyte lysate test for endotoxaemia.

Authors:  T Obayashi; T Kawai; H Tamura; C Nakahara
Journal:  Lancet       Date:  1982-01-30       Impact factor: 79.321

5.  Evaluation of a chromogenic method for endotoxin measurement.

Authors:  M F Scully; Y M Newman; S E Clark; V V Kakkar
Journal:  Thromb Res       Date:  1980-10-15       Impact factor: 3.944

6.  Principles of a quantitative assay for bacterial endotoxins in blood that uses Limulus lysate and a chromogenic substrate.

Authors:  C J Webster
Journal:  J Clin Microbiol       Date:  1980-11       Impact factor: 5.948

7.  New function for high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma.

Authors:  R J Ulevitch; A R Johnston; D B Weinstein
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

8.  Chromogenic substrates for horseshoe crab clotting enzyme. Its application for the assay of bacterial endotoxins.

Authors:  S Iwanaga; T Morita; T Harada; S Nakamura; M Niwa; K Takada; T Kimura; S Sakakibara
Journal:  Haemostasis       Date:  1978

9.  Portal venous and systemic endotoxaemia in patients without liver disease and systemic endotoxaemia in patients with cirrhosis.

Authors:  H Prytz; J Holst-Christensen; B Korner; H Liehr
Journal:  Scand J Gastroenterol       Date:  1976       Impact factor: 2.423

10.  An invertebrate coagulation system activated by endotoxin: evidence for enzymatic mediation.

Authors:  N S Young; J Levin; R A Prendergast
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

View more
  16 in total

1.  Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide.

Authors:  C Thiemermann; C Szabó; J A Mitchell; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

2.  Risk factors for urosepsis following percutaneous nephrolithotomy: role of 1 week of nitrofurantoin in reducing the risk of urosepsis.

Authors:  Santosh Kumar; Sanand Bag; Raguram Ganesamoni; Arup K Mandal; Neelam Taneja; Shrawan Kumar Singh
Journal:  Urol Res       Date:  2011-05-13

3.  Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis.

Authors:  H R Alexander; B C Sheppard; J C Jensen; H N Langstein; C M Buresh; D Venzon; E C Walker; D L Fraker; M C Stovroff; J A Norton
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

4.  Effect of anticoagulants on the chromogenic Limulus lysate assay for endotoxin.

Authors:  J S McConnell; J Cohen
Journal:  J Clin Pathol       Date:  1985-04       Impact factor: 3.411

5.  A micromethod for endotoxin assay in human plasma using Limulus amoebocyte lysate and a chromogenic substrate.

Authors:  B I Piotrowicz; I Watt; S Edlin; A C McCartney
Journal:  Eur J Clin Microbiol       Date:  1985-02       Impact factor: 3.267

6.  Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice.

Authors:  H W Harris; C Grunfeld; K R Feingold; J H Rapp
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

7.  Endotoxaemia as a cause of fever in immunosuppressed patients.

Authors:  R I Harris; P C Stone; G R Evans; J Stuart
Journal:  J Clin Pathol       Date:  1984-04       Impact factor: 3.411

8.  Endotoxin testing revisited.

Authors:  A Sturk; J W ten Cate
Journal:  Eur J Clin Microbiol       Date:  1985-08       Impact factor: 3.267

9.  Chromogenic Limulus amoebocyte lysate assay for rapid detection of gram-negative bacteriuria.

Authors:  R Nachum; R N Berzofsky
Journal:  J Clin Microbiol       Date:  1985-05       Impact factor: 5.948

10.  Chylomicrons enhance endotoxin excretion in bile.

Authors:  T E Read; H W Harris; C Grunfeld; K R Feingold; M C Calhoun; J P Kane; J H Rapp
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.